The Analysis of the Action Mechanisms of Novel Steroid Compounds for the Induction of TSLP Production

[1]

‘Autoimmunity : Introduction | British Society for Immunology’.

https://www.immunology.org/public-information/bitesized-immunology/immunedysfunction/autoimmunity-introduction (accessed Jun. 09, 2020).

[2]

M. D. Rosenblum, I. K. Gratz, J. S. Paw, and A. K. Abbas, ‘Treating human

autoimmunity: Current practice and future prospects’, Science Translational

Medicine,

vol.

4,

no.

125.

Sci

Transl

Med,

Mar.

14,

2012.

doi:

10.1126/scitranslmed.3003504.

[3]

J. W. Jiang et al., ‘Optimal immunosuppressor induces stable gut microbiota after

liver transplantation’, World J Gastroenterol, vol. 24, no. 34, pp. 3871–3883, Sep.

2018, doi: 10.3748/wjg.v24.i34.3871.

[4]

S. Yang et al., ‘The role of mitochondria in systemic lupus erythematosus: A glimpse

of various pathogenetic mechanisms’, Curr Med Chem, vol. 26, Nov. 2018, doi:

10.2174/0929867326666181126165139.

[5]

M. Yu, M. Liu, W. Zhang, and Y. Ming, ‘Pharmacokinetics, Pharmacodynamics and

Pharmacogenetics of Tacrolimus in Kidney Transplantation’, Curr Drug Metab, vol.

19, no. 6, pp. 513–522, Jan. 2018, doi: 10.2174/1389200219666180129151948.

[6]

L. Göschl, C. Scheinecker, and M. Bonelli, ‘Treg cells in autoimmunity: from

identification to Treg-based therapies’, Seminars in Immunopathology, vol. 41, no.

3. Springer Verlag, pp. 301–314, May 01, 2019. doi: 10.1007/s00281-019-00741-8.

[7]

T. R. Malek, ‘The Biology of Interleukin-2’, Annual review of stem cell development,

vol. 26, no. Annu. Rev. Immunol. 2008. 26:453–79 First, pp. 453–479, Mar. 2008, doi:

10.1146/annurev.immunol.26.021607.090357.

[8]

T. Yamaguchi et al., ‘Construction of self-recognizing regulatory T cells from

conventional T cells by controlling CTLA-4 and IL-2 expression’, Proc Natl Acad Sci

U S A, vol. 110, no. 23, pp. E2116–E2125, Jun. 2013, doi: 10.1073/pnas.1307185110.

[9]

J. Corren and S. F. Ziegler, ‘TSLP: from allergy to cancer’, Nature Immunology, vol.

20, no. 12. Nature Research, pp. 1603–1609, Dec. 01, 2019. doi: 10.1038/s41590-01961

0524-9.

[10]

F. Roan, K. Obata-Ninomiya, and S. F. Ziegler, ‘Epithelial cell–derived cytokines: More

than just signaling the alarm’, Journal of Clinical Investigation, vol. 129, no. 4.

American Society for Clinical Investigation, pp. 1441–1451, Apr. 01, 2019. doi:

10.1172/JCI124606.

[11]

J. Y. Lee et al., ‘Murine thymic stromal lymphopoietin promotes the differentiation of

regulatory T cells from thymic CD4+CD8-CD25- naïve cells in a dendritic cellindependent manner’, Immunol Cell Biol, vol. 86, no. 2, pp. 206–213, Feb. 2008, doi:

10.1038/sj.icb.7100127.

[12]

M. Kitajima, H. C. Lee, T. Nakayama, and S. F. Ziegler, ‘TSLP enhances the function of

helper type 2 cells’, Eur J Immunol, vol. 41, no. 7, pp. 1862–1871, Jul. 2011, doi:

10.1002/eji.201041195.

[13]

Q. Jiang, H. Su, G. Knudsen, W. Helms, and L. Su, ‘Delayed functional maturation of

natural regulatory T cells in the medulla of postnatal thymus: Role of TSLP’, BMC

Immunol, vol. 7, Apr. 2006, doi: 10.1186/1471-2172-7-6.

[14]

G. Besin, S. Gaudreau, M. Menard, C. Guindi, G. Dupuis, and A. Amrani, ‘Thymic

stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells

induce regulatory T-cell differentiation and protection of NOD mice against

diabetes’, Diabetes, vol. 57, no. 8, pp. 2107–2117, Aug. 2008, doi: 10.2337/db080171.

[15]

V. Moosbrugger-Martinz, M. Schmuth, and S. Dubrac, ‘A Mouse Model for Atopic

Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903’, Methods

in Molecular Biology, vol. 1559, pp. 91–106, 2017, doi: 10.1007/978-1-4939-6786-5_8.

[16]

A. Briot, M. Lacroix, A. Robin, M. Steinhoff, C. Deraison, and A. Hovnanian, ‘Par2

inactivation inhibits early production of TSLP, but not cutaneous inflammation, in

Netherton syndrome adult mouse model’, J Invest Dermatol, vol. 130, no. 12, pp.

2736–2742, 2010, doi: 10.1038/JID.2010.233.

[17]

D. S. Ferreira et al., ‘Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin

expression in fatal asthma’, Clin Exp Allergy, vol. 42, no. 10, pp. 1459–1471, Oct. 2012,

doi: 10.1111/J.1365-2222.2012.04047.X.

62

[18]

R. Segawa et al., ‘EGFR transactivation is involved in TNF-α-induced expression of

thymic stromal lymphopoietin in human keratinocyte cell line’, J Dermatol Sci, vol.

89, no. 3, pp. 290–298, Mar. 2018, doi: 10.1016/J.JDERMSCI.2017.12.008.

[19]

Y. Jang et al., ‘UVB induces HIF-1α-dependent TSLP expression via the JNK and ERK

pathways’, J Invest Dermatol, vol. 133, no. 11, pp. 2601–2608, 2013, doi:

10.1038/JID.2013.203.

[20]

W. I. Ryu, H. Lee, J. H. Kim, H. C. Bae, H. J. Ryu, and S. W. Son, ‘IL-33 induces Egr-1dependent TSLP expression via the MAPK pathways in human keratinocytes’, Exp

Dermatol, vol. 24, no. 11, pp. 857–863, Nov. 2015, doi: 10.1111/EXD.12788.

[21]

J. Kang, J. Song, S. Shen, B. Li, X. Yang, and M. Chen, ‘Diisononyl phthalate aggravates

allergic dermatitis by activation of NF-kB’, Oncotarget, vol. 7, no. 51, pp. 85472–

85482, 2016, doi: 10.18632/ONCOTARGET.13403.

[22]

N. Mizuno et al., ‘Pentanoic acid induces thymic stromal lymphopoietin production

through

Gq/11

and

Rho-associated

protein

kinase

signaling

pathway

in

keratinocytes’, Int Immunopharmacol, vol. 50, pp. 216–223, Sep. 2017, doi:

10.1016/J.INTIMP.2017.06.024.

[23]

M. Li, P. Hener, Z. Zhang, S. Kato, D. Metzger, and P. Chambon, ‘Topical vitamin D3

and low-calcemic analogs induce thymic stromal lymphopoietin in mouse

keratinocytes and trigger an atopic dermatitis’, Proc Natl Acad Sci U S A, vol. 103, no.

31, pp. 11736–11741, Aug. 2006, doi: 10.1073/pnas.0604575103.

[24]

Y. Weng et al., ‘Induction of thymic stromal lymphopoietin by a steroid alkaloid

derivative in mouse keratinocytes’, Int Immunopharmacol, vol. 55, pp. 28–37, Feb.

2018, doi: 10.1016/J.INTIMP.2017.11.045.

[25]

J. L. Barlow et al., ‘IL-33 is more potent than IL-25 in provoking IL-13-producing

nuocytes (type 2 innate lymphoid cells) and airway contraction’, Journal of Allergy

and Clinical Immunology, vol. 132, no. 4, pp. 933–941, Oct. 2013, doi:

10.1016/j.jaci.2013.05.012.

[26]

H. C. Lee and S. F. Ziegler, ‘Inducible expression of the proallergic cytokine thymic

stromal lymphopoietin in airway epithelial cells is controlled by NFκB’, Proc Natl Acad

Sci U S A, vol. 104, no. 3, pp. 914–919, Jan. 2007, doi: 10.1073/pnas.0607305104.

63

[27]

Y. H. Wang et al., ‘IL-25 augments type 2 immune responses by enhancing the

expansion and functions of TSLP-DC-activated Th2 memory cells’, Journal of

Experimental Medicine, vol. 204, no. 8, pp. 1837–1847, Aug. 2007, doi:

10.1084/jem.20070406.

[28]

Y. Weng et al., ‘Induction of thymic stromal lymphopoietin by a steroid alkaloid

derivative in mouse keratinocytes’, Int Immunopharmacol, vol. 55, pp. 28–37, Feb.

2018, doi: 10.1016/j.intimp.2017.11.045.

[29]

K. Zhang, L. Shan, M. S. Rahman, H. Unruh, A. J. Halayko, and A. S. Gounni,

‘Constitutive and inducible thymic stromal lymphopoietin expression in human

airway smooth muscle cells: Role in chronic obstructive pulmonary disease’, Am J

Physiol

Lung

Cell

Mol

Physiol,

vol.

293,

no.

2,

Aug.

2007,

doi:

10.1152/ajplung.00045.2007.

[30]

K. DeFea, ‘β-arrestins and heterotrimeric G-proteins: Collaborators and competitors

in signal transduction’, in British Journal of Pharmacology, Wiley-Blackwell, Mar.

2008, p. S298. doi: 10.1038/sj.bjp.0707508.

[31]

H. Fan, ‘β-Arrestins 1 and 2 are critical regulators of inflammation’, Innate Immunity,

vol. 20, no. 5. SAGE Publications Ltd, pp. 451–460, Jul. 12, 2014. doi:

10.1177/1753425913501098.

[32]

S. zhen Sun et al., ‘β-Arrestin 2 mediates arginine vasopressin-induced IL-6

induction via the ERK1/2-NF-κB signal pathway in murine hearts’, Acta Pharmacol

Sin, vol. 41, no. 2, pp. 198–207, Feb. 2020, doi: 10.1038/s41401-019-0292-y.

[33]

M. Grundmann et al., ‘Lack of beta-arrestin signaling in the absence of active G

proteins’, Nat Commun, vol. 9, no. 1, Dec. 2018, doi: 10.1038/s41467-017-02661-3.

[34]

D. Fu, P. Li, Q. Sheng, and Z. Lv, ‘β-arrestin-2 enhances intestinal epithelial apoptosis

in necrotizing enterocolitis’, Aging, vol. 11, no. 19, pp. 8294–8312, 2019, doi:

10.18632/AGING.102320.

[35]

G. Besin, S. Gaudreau, M. Menard, C. Guindi, G. Dupuis, and A. Amrani, ‘Thymic

stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells

induce regulatory T-cell differentiation and protection of NOD mice against

diabetes’, Diabetes, vol. 57, no. 8, pp. 2107–2117, Aug. 2008, doi: 10.2337/db0864

0171.

[36]

Y. Weng et al., ‘Induction of thymic stromal lymphopoietin by a steroid alkaloid

derivative in mouse keratinocytes’, Int Immunopharmacol, vol. 55, pp. 28–37, Feb.

2018, doi: 10.1016/j.intimp.2017.11.045.

[37]

Y. S. Yi, ‘Role of inflammasomes in inflammatory autoimmune rheumatic diseases’,

Korean Journal of Physiology and Pharmacology, vol. 22, no. 1. Korean Physiological

Soc. and Korean Soc. of Pharmacology, pp. 1–15, Jan. 01, 2018. doi:

10.4196/kjpp.2018.22.1.1.

[38]

S. I. Bogiatzi et al., ‘Cutting Edge: Proinflammatory and Th2 Cytokines Synergize to

Induce Thymic Stromal Lymphopoietin Production by Human Skin Keratinocytes’,

The Journal of Immunology, vol. 178, no. 6, pp. 3373–3377, Mar. 2007, doi:

10.4049/jimmunol.178.6.3373.

[39]

N. Mizuno et al., ‘Pentanoic acid induces thymic stromal lymphopoietin production

through

Gq/11

and

Rho-associated

protein

kinase

signaling

pathway

in

keratinocytes’, Int Immunopharmacol, vol. 50, pp. 216–223, Sep. 2017, doi:

10.1016/j.intimp.2017.06.024.

[40]

Y. Wang et al., ‘Selective induction of thymic stromal lymphopoietin expression by

novel nitrogen-containing steroid compounds in PAM-212 cells’, J Transl

Autoimmun, p. 100186, Dec. 2022, doi: 10.1016/J.JTAUTO.2022.100186.

[41]

W. Shi et al., ‘MEK/ERK signaling pathway is required for enterovirus 71 replication

in immature dendritic cells’, Virol J, vol. 11, no. 1, Dec. 2014, doi: 10.1186/s12985014-0227-7.

[42]

P. H. Sugden and A. Clerk, ‘Regulation of the ERK subgroup of MAP kinase cascades

through G protein-coupled receptors’, Cellular Signalling, vol. 9, no. 5. Cell Signal,

pp. 337–351, Aug. 1997. doi: 10.1016/S0898-6568(96)00191-X.

[43]

V. M. Zohrabian, B. Forzani, Z. Chau, R. Murali, and M. Jhanwar-Uniyal, ‘Rho/ROCK

and MAPK signaling pathways are involved in glioblastoma cell migration and

proliferation’, Anticancer Res, vol. 29, no. 1, pp. 119–123, Jan. 2009.

[44]

J. H. Park, J. M. Ryu, S. P. Yun, M. O. Kim, and H. J. Han, ‘Fibronectin stimulates

migration through lipid raft dependent NHE-1 activation in mouse embryonic stem

65

cells: Involvement of RhoA, Ca 2 +/CaM, and ERK’, Biochimica et Biophysica Acta

(BBA) - General Subjects, vol. 1820, no. 10, pp. 1618–1627, Oct. 2012, doi:

10.1016/j.bbagen.2012.05.013.

[45]

A. Briot et al., ‘Kallikrein 5 induces atopic dermatitis-like lesions through PAR2mediated thymic stromal lymphopoietin expression in Netherton syndrome’, Journal

of Experimental Medicine, vol. 206, no. 5, pp. 1135–1147, May 2009, doi:

10.1084/jem.20082242.

[46]

R. Segawa et al., ‘EGFR transactivation is involved in TNF-α-induced expression of

thymic stromal lymphopoietin in human keratinocyte cell line’, J Dermatol Sci, vol.

89, no. 3, pp. 290–298, Mar. 2018, doi: 10.1016/j.jdermsci.2017.12.008.

[47]

A. T. Vu et al., ‘Staphylococcus aureus membrane and diacylated lipopeptide induce

thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Tolllike receptor 6 pathway’, Journal of Allergy and Clinical Immunology, vol. 126, no. 5,

2010, doi: 10.1016/j.jaci.2010.09.002.

[48]

K. Schaper et al., ‘Stimulation of the histamine 4 receptor upregulates thymic stromal

lymphopoietin (TSLP) in human and murine keratinocytes’, Pharmacol Res, vol. 113,

no. Pt A, pp. 209–215, Nov. 2016, doi: 10.1016/j.phrs.2016.08.001.

[49]

S. F. Ziegler, F. Roan, B. D. Bell, T. A. Stoklasek, M. Kitajima, and H. Han, ‘The Biology

of Thymic Stromal Lymphopoietin (TSLP)’, in Advances in Pharmacology, Academic

Press Inc., 2013, pp. 129–155. doi: 10.1016/B978-0-12-404717-4.00004-4.

[50]

M. Rimoldi et al., ‘Intestinal immune homeostasis is regulated by the crosstalk

between epithelial cells and dendritic cells’, Nat Immunol, vol. 6, no. 5, pp. 507–514,

2005, doi: 10.1038/ni1192.

[51]

L. H. Zeuthen, L. N. Fink, and H. Frokiaer, ‘Epithelial cells prime the immune response

to an array of gut-derived commensals towards a tolerogenic phenotype through

distinct actions of thymic stromal lymphopoietin and transforming growth factor-β’,

Immunology, vol. 123, no. 2, pp. 197–208, Feb. 2008, doi: 10.1111/j.13652567.2007.02687.x.

[52]

L. de Monte et al., ‘Intratumor T helper type 2 cell infiltrate correlates with cancerassociated fibroblast thymic stromal lymphopoietin production and reduced survival

66

in pancreatic cancer’, Journal of Experimental Medicine, vol. 208, no. 3, pp. 469–478,

Mar. 2011, doi: 10.1084/jem.20101876.

[53]

A. Pedroza-Gonzalez et al., ‘Thymic stromal lymphopoietin fosters human breast

tumor growth by promoting type 2 inflammation’, Journal of Experimental Medicine,

vol. 208, no. 3, pp. 479–490, Mar. 2011, doi: 10.1084/jem.20102131.

67

9. Supplemental Fig.

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

68

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

69

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Name

code

and

formula

TSLP-induced activity

Supplemental Fig. The compounds structural formula and TSLP-induced activity

70

...